Ida Häggström

Dr. Ida Häggström

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
Marius MayerhoeferMarius Mayerhoefer
Marius Mayerhoefer
AMAndrzej Materka
Andrzej Materka
GLGeorg Langs
Georg Langs
IHIda Häggström
Ida Häggström
PSPiotr Szczypiński
Piotr Szczypiński
GCGary Cook
Gary Cook
Radiomics is a rapidly evolving field of research concerned with the extraction and quantification of patterns – the so-called radiomic features – within medical images. Radiomic features capture tissue and lesion characteristics such as heterogeneity and shape, and may, alone or in combination with demographic, histological, genomic or proteomic data, be used for clinical problem-solving. The goal of this CE article is to provide an introduction to the field, covering the basic radiomics workflow:feature calculation and selection, dimensionality reduction, and data processing using tools such as machine learning. Potential clinical applications in nuclear medicine that include prediction of treatment response and survival based on PET radiomic features will be discussed. Current limitations of radiomics, including its sensitivity to image acquisition parameter variations, and common pitfalls such as “overfitting”, will also be covered.

1 May 2019 in Medical Image Analysis
Verified
Journal Article
Closed access
IHIda Häggström
Ida Häggström
CSC. Ross Schmidtlein
C. Ross Schmidtlein
GCGabriele Campanella
Gabriele Campanella
TFThomas J. Fuchs
Thomas J. Fuchs

9 July 2025 in Nature Medicine
Verified
Journal Article
Open access
PDF file
GCGabriele Campanella
Gabriele Campanella
NKNeeraj Kumar
Neeraj Kumar
SNSwaraj Nanda
Swaraj Nanda
SSSiddharth Singi
Siddharth Singi
EFEugene Fluder
Eugene Fluder
CVChad Vanderbilt
Chad Vanderbilt
Artificial intelligence models using digital histopathology slides stained with hematoxylin and eosin offer promising, tissue-preserving diagnostic tools for patients with cancer. Despite their advantages, their clinical utility in real-world settings remains unproven. Assessing EGFR mutations in lung adenocarcinoma demands rapid, accurate and cost-effective tests that preserve tissue for genomic sequencing. PCR-based assays provide rapid results but with reduced accuracy compared with next-generation sequencing and require additional tissue. Computational biomarkers leveraging modern foundation models can address these limitations. Here we assembled a large international clinical dataset of digital lung adenocarcinoma slides (N = 8,461) to develop a computational EGFR biomarker. Our model fine-tunes an open-source foundation model, improving task-specific performance with out-of-center generalization and clinical-grade accuracy on primary and metastatic specimens (mean area under the curve: internal 0.847, external 0.870). To evaluate real-world clinical translation, we conducted a prospective silent trial of the biomarker on primary samples, achieving an area under the curve of 0.890. The artificial-intelligence-assisted workflow reduced the number of rapid molecular tests needed by up to 43% while maintaining the current clinical standard performance. Our retrospective and prospective analyses demonstrate the real-world clinical utility of a computational pathology biomarker.

1 August 2020 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
EKElena A. Kaye
Elena A. Kaye
EAEmily A. Aherne
Emily A. Aherne
CDCihan Duzgol
Cihan Duzgol
IHIda Häggström
Ida Häggström
EKErich Kobler
Erich Kobler
OAOguz Akin
Oguz Akin
A convolutional neural network trained on the pairs of low and high signal-to-noise ratio diffusion-weighted (DW) images from 103 prostate scans successfully denoised the DW images acquired with tw... PurposeTo investigate the feasibility of accelerating prostate diffusion-weighted imaging (DWI) by reducing the number of acquired averages and denoising the resulting image using a proposed guided...

27 May 2016 in Medical Physics
Verified
Journal Article
Closed access
IHIda Häggström
Ida Häggström
BBBradley J. Beattie
Bradley J. Beattie
CSC. Ross Schmidtlein
C. Ross Schmidtlein

22 May 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
HJHoor Jalo
Hoor Jalo
MSMattias Seth
Mattias Seth
MPMinna Pikkarainen
Minna Pikkarainen
IHIda Häggström
Ida Häggström
KJKatarina Jood
Katarina Jood
SCStefan Candefjord
Stefan Candefjord
Introduction Stroke is a time-critical condition and one of the leading causes of mortality and disability worldwide. To decrease mortality and improve patient outcome by improving access to optimal treatment, there is an emerging need to improve the accuracy of the methods used to identify and characterise stroke in prehospital settings and emergency departments (EDs). This might be accomplished by developing computerised decision support systems (CDSSs) that are based on artificial intelligence (AI) and potential new data sources such as vital signs, biomarkers and image and video analysis. This scoping review aims to summarise literature on existing methods for early characterisation of stroke by using AI. Methods and analysis The review will be performed with respect to the Arksey and O’Malley’s model. Peer-reviewed articles about AI-based CDSSs for the characterisation of stroke or new potential data sources for stroke CDSSs, published between January 1995 and April 2023 and written in English, will be included. Studies reporting methods that depend on mobile CT scanning or with no focus on prehospital or ED care will be excluded. Screening will be done in two steps: title and abstract screening followed by full-text screening. Two reviewers will perform the screening process independently, and a third reviewer will be involved in case of disagreement. Final decision will be made based on majority vote. Results will be reported using a descriptive summary and thematic analysis. Ethics and dissemination The methodology used in the protocol is based on information publicly available and does not need ethical approval. The results from the review will be submitted for publication in a peer-reviewed journal. The findings will be shared at relevant national and international conferences and meetings in the field of digital health and neurology.